The phantom of lactic acidosis due to metformin in patients with diabetes.
Misbin
Robert I
RI
Division of Endocrinology and Metabolism, Food and Drug Administration, Rockville, MD 20851, USA. misbinr@cder.fda.gov
D000140:Acidosis, Lactic / Q000139:chemically induced*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008687:Metformin / Q000008:administration & dosage / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D008687:Metformin